A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

Adding Xtandi to androgen deprivation therapy and radiation did not significantly improve metastasis-free survival in ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

MEN with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

Researchers found that patients who took statins alongside apalutamide and standard hormone therapy had higher three-year ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...